An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life.

ACS Chem Biol

Departments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.

Published: January 2017

Prescription opioids (POs) such as oxycodone and hydrocodone are highly effective medications for pain management, yet they also present a substantial risk for abuse and addiction. The consumption of POs has been escalating worldwide, resulting in tens of thousands of deaths due to overdose each year. Pharmacokinetic strategies based upon vaccination present an attractive avenue to suppress PO abuse. Herein, the preparation of two active PO vaccines is described that were found to elicit high-affinity antiopioid antibodies through a structurally congruent drug-hapten design. Administration of these vaccines resulted in a significant blockade of opioid analgesic activity, along with an unprecedented increase in drug serum half-life and protection against lethal overdose.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434689PMC
http://dx.doi.org/10.1021/acschembio.6b00977DOI Listing

Publication Analysis

Top Keywords

advance prescription
4
prescription opioid
4
opioid vaccines
4
vaccines overdose
4
overdose mortality
4
mortality reduction
4
reduction extraordinary
4
extraordinary alteration
4
alteration drug
4
drug half-life
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!